Vital Signs The Analyst's Perspective - July 2015 Issue

USD 450.00

* Required Fields

USD 450.00


Be the first to review this product

This issue of Vital Signs, released in August 2015, discusses The Real Fight Against Cancer: The Struggle to make Drugs Affordable, OPKO Health's acquisition of Bio-Reference Laboratories, Health Insurance Company Mergers – How will Consumers Fare?, and Illumina's acquisition of GenoLogics.

Table of Contents

Vital Signs The Analyst's Perspective - July 2015 IssueVital Signs - July 2015 IssueThis month's issue

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.